Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.

PUBLICATIONS

350+

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Formenti et al.

  • Nature Medicine
  • December 2018

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells

Ruck et al.

  • Neurology
  • December 2018

MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors

Juric et al.

  • PLOS ONE
  • November 2018

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Blank et al.

  • Nature Medicine
  • November 2018

Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire

Tarhini et al.

  • Journal for ImmunoTherapy of Cancer
  • October 2018

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

Ruella et al.

  • Nature Medicine
  • October 2018

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Fraietta et al.

  • Nature
  • Papers
  • May 2018

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Ariyan et al.

  • Cancer Immunology Research
  • Papers
  • April 2018

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

Wrangle et al.

  • Lancet Oncology
  • Papers
  • April 2018
back_to_top